Search

Your selections:

Subject HIV/AIDS-Zambia Remove constraint Subject: HIV/AIDS-Zambia Year 2015 Remove constraint Year: 2015 Start Over

Search Results

Mpande, Mutandwa Norman
2015·University of Zambia

Atazanavir-ritonavir (ATV-r) has been recommended by the World Health Organization as part of second-line combination antiretroviral therapy (cART) in HIV-infected patients aged 6 years and above. In 2013, the Zambia HIV treatment program introduced ATV-ras an alternative Protease Inhibitor (PI)...

Download PDF ↓